Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 7;11(4):602-8.
doi: 10.2215/CJN.08080715. Epub 2016 Jan 19.

Peripheral Edema, Central Venous Pressure, and Risk of AKI in Critical Illness

Affiliations

Peripheral Edema, Central Venous Pressure, and Risk of AKI in Critical Illness

Kenneth P Chen et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Although venous congestion has been linked to renal dysfunction in heart failure, its significance in a broader context has not been investigated.

Design, setting, participants, & measurements: Using an inception cohort of 12,778 critically ill adult patients admitted to an urban tertiary medical center between 2001 and 2008, we examined whether the presence of peripheral edema on admission physical examination was associated with an increased risk of AKI within the first 7 days of critical illness. In addition, in those with admission central venous pressure (CVP) measurements, we examined the association of CVPs with subsequent AKI. AKI was defined using the Kidney Disease Improving Global Outcomes criteria.

Results: Of the 18% (n=2338) of patients with peripheral edema on admission, 27% (n=631) developed AKI, compared with 16% (n=1713) of those without peripheral edema. In a model that included adjustment for comorbidities, severity of illness, and the presence of pulmonary edema, peripheral edema was associated with a 30% higher risk of AKI (95% confidence interval [95% CI], 1.15 to 1.46; P<0.001), whereas pulmonary edema was not significantly related to risk. Peripheral edema was also associated with a 13% higher adjusted risk of a higher AKI stage (95% CI, 1.07 to 1.20; P<0.001). Furthermore, levels of trace, 1+, 2+, and 3+ edema were associated with 34% (95% CI, 1.10 to 1.65), 17% (95% CI, 0.96 to 1.14), 47% (95% CI, 1.18 to 1.83), and 57% (95% CI, 1.07 to 2.31) higher adjusted risk of AKI, respectively, compared with edema-free patients. In the 4761 patients with admission CVP measurements, each 1 cm H2O higher CVP was associated with a 2% higher adjusted risk of AKI (95% CI, 1.00 to 1.03; P=0.02).

Conclusions: Venous congestion, as manifested as either peripheral edema or increased CVP, is directly associated with AKI in critically ill patients. Whether treatment of venous congestion with diuretics can modify this risk will require further study.

Keywords: acute kidney injury; acute renal failure; central venous pressure; comorbidity; critical illness; edema; heart failure; humans; pulmonary edema; renal function.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Incidence of AKI severity according to peripheral edema severity.
Figure 2.
Figure 2.
Forest plot for risk of peripheral edema and AKI per subgroup. Adjusted for age, gender, race, intensive care unit type, Sequential Organ Failure Assessment, history of diabetes, congestive heart failure, hypertension, chronic pulmonary disease, peripheral vascular disease, and 24 additional Elixhauser comorbidities, admission vitals (systolic and diastolic BP, heart rate, temperature), admission creatinine, preillness medication usage (angiotensin inhibitor converting enzyme-inhibitor, angiotensin receptor blocker, statin, calcium channel blocker, and diuretics), and pulmonary edema (excluded in pulmonary edema stratification). eGFR calculated from admission serum creatinine concentration using the Modified Diet in Renal Disease equation.

Similar articles

Cited by

References

    1. Winton FR: The influence of venous pressure on the isolated mammalian kidney. J Physiol 72: 49–61, 1931 - PMC - PubMed
    1. Winton FR: The glomerular pressure in the isolated mammalian kidney. J Physiol 72: 361–375, 1931 - PMC - PubMed
    1. Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, Kirkpatrick JN: Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105: 511–516, 2010 - PMC - PubMed
    1. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589–596, 2009 - PMC - PubMed
    1. House AA: Cardiorenal syndrome: new developments in the understanding and pharmacologic management. Clin J Am Soc Nephrol 8: 1808–1815, 2013 - PMC - PubMed

Publication types